June 2026 Edition
About the Newsletter
Each edition draws from RegulatoryID, MedPro's expert-maintained reference covering transparency and compliance requirements across 50+ countries. The team that maintains the compendium also curates each newsletter, surfacing the deadlines, filings and rule changes most relevant to Life Sciences manufacturers, distributors and medical device companies in the month ahead.
What You Receive Each Month
A single monthly newsletter delivered the first Tuesday of each month, covering U.S. and international jurisdictions
Concise high-level summaries in the email so you can quickly scan deadlines and what's required
Linked detailed summaries with full regulatory context, deadlines and reference links
Immediate alerts for urgent developments that cannot wait for the next monthly send
Inside the June Edition
Ten filing windows opening between June 30 and July 1, spanning U.S. state and international jurisdictions. Subscribe to access the full requirements, source links and submission detail for each.
Connecticut PMF Registration & Report Due 6/30
A pharmaceutical manufacturer that employs a pharmaceutical sales representative must register annually with the Department of Consumer Protection (the Department) as a pharmaceutical marketing firm. Registrations must be renewed annually by June 30.
Additionally, pharmaceutical marketing firms must provide the Commissioner of Consumer Protection (the Commissioner) with a report for the previous calendar year describing the activities of pharmaceutical representative(s).
Connecticut APRN Report Due 7/1
Drug, device, biological and medical supply manufacturers must report transfers of value made to Advanced Practice Registered Nurses (APRNs) who are independently practicing (i.e., practicing not in collaboration with a physician in the state) by July 1 annually for the preceding calendar year.
Massachusetts Pharmaceutical Code of Conduct Due 7/1
Massachusetts pharmaceutical and medical device manufacturers that sell or market prescription drugs or devices in the state must comply with the Massachusetts Marketing Code of Conduct and annually renew their registration by July 1, including payment of the $2,000 fee and compliance attestation. Manufacturers must also submit a transparency/disclosure report by July 1 for reportable payments or benefits of $50 or more made to covered recipients in the prior calendar year, using required Massachusetts company and covered recipient IDs.
Florida Miami-Dade Lobbyist Expenditures Report Due 7/1
Drug, device, biological and medical supply manufacturers must report transfers of value made to Advanced Practice Registered Nurses (APRNs) who are independently practicing (i.e., practicing not in collaboration with a physician in the state) by July 1 annually for the preceding calendar year.
D.C. Prescription Drug Marketing Cost Report Due 7/1
Prescription drug manufacturers and labelers that employ, direct or utilize marketing representatives in D.C. must report to the Department of Health their marketing costs for prescription drugs in the District for the preceding calendar year. Reports must be submitted annually via email by July 1.
EFPIA Disclosures Due 6/30
Under the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice, members of EFPIA must disclose by June 30, 2026, direct or indirect transfers of value (ToVs) made during the prior calendar year to healthcare professionals (HCPs), healthcare organizations (HCOs) and patient organizations (POs). Commencing 2026, EFPIA requires companies use a standardized template structure for methodological notes accompanying disclosed 2025 ToVs.
MedTech Europe Disclosures Due 6/30
Under the MedTech Europe Code of Ethical Business Practice Disclosure Guidelines ("Disclosure Guidelines"), MedTech member companies must disclose all educational grants made during the prior calendar year to healthcare organizations (HCOs) registered or based in the MedTech geographic area by June 30. An update to the Disclosure Guidelines requires companies to gear up for a new disclosure process MedTech will instate in 2027.
Mecomed Disclosures Due 6/30
Member companies of Mecomed must annually disclose educational grants made during the previous calendar year to healthcare organizations (HCOs) and professional conference organizers (PCOs) based or registered in the Mecomed geographic area by June 30 via the Mecomed central platform, Mecomed Disclosure.
Greece Disclosures Under Both Law and Industry Code Due 6/30
Companies engaged in covered interactions with healthcare providers (HCPs) or healthcare organizations (HCOs) based in Greece must annually disclose by June 30 to the National Organization for Medicines (EOF) relevant benefits granted directly or indirectly as required under Greek Law 4316/2014. In practice, the EOF has applied this disclosure obligation to companies producing products under jurisdiction of the EOF, which includes both pharmaceutical products and medical devices. Members of the Hellenic Association of Pharmaceutical Companies (SFEE) must also disclose information regarding relevant transfers of value granted to HCPs, HCOs and patient organizations (POs) by June 30.
Lithuania Disclosures Under Both Law and Industry Code Due 6/30
Companies with market authorization, or their representatives, in the Republic of Lithuania must submit information about transfers of value (ToVs) provided to healthcare or pharmaceutical specialists and specified legal entities to the State Medicines Control Agency (VVKT) under the Law on Pharmacy by June 30. Additionally, members of the Innovative Pharmaceutical Industry Association (IFPA) and the Medicinal Product Manufacturers Association (VGA) must disclose information regarding relevant ToVs to healthcare professionals (HCPs), healthcare organizations (HCOs) or patient organizations (POs).
Subscribe to the RegulatoryID Newsletter
Enter your work email to request access to the full May 2026 edition and to receive ongoing updates direct to your inbox.